Alexander M. Lodge



Alexander Lodge, Ph.D., is an associate with Foley & Lardner LLP, where he is a member of the firm’s Chemical, Biotechnology & Pharmaceutical Practice.

Dr. Lodge focuses his practice on patent procurement, both U.S. and foreign prosecution, assessing risk mitigation through freedom-to-operate and invalidity opinions and IP patent portfolio management. Dr. Lodge’s practice experience extends to chemical patent technology areas that include small molecule chemistry, pharmaceuticals, batteries, catalysts, polymers, electrochemistry, biofuels, organic and enzymatic synthetic methods, adhesives, paints and coatings, nanotechnology, composites and medical devices.

In 2015, Dr. Lodge was a summer associate with Foley in the firm’s Madison office. He also worked as a research assistant with the University of Iowa College of Law, where he conducted research on cases and current issues in patent law, and generated a database of Federal Circuit Court of Appeals on slip opinions mapping trends in patent decisions for academic writing.


  • University of Iowa, College of Law (J.D., 2016)
  • University of Iowa (Ph.D., 2013)
    • Chemistry
  • Grambling State University (B.S., summa cum laude, 2006)
    • Chemistry

Admissions and Professional Memberships

  • Wisconsin
  • U.S. District Court for the Western District of Wisconsin
  • Member, American Intellectual Property Law Association
  • Member, National Bar Association
  • Member, Wisconsin Association for African-American Lawyers
  • Member, American Chemical Society

Community Engagement

Dr. Lodge is actively involved as a mentor with Big Brothers Big Sisters, the Kappa Alpha Psi Guide Right Program, and leads pro bono efforts related to conviction expungement and arrest record correction in the Greater Madison, Wisconsin area.


  • Co-author, “USPTO Withdraws Newly Characterized Antigen Test For Written Description Of Antibodies.” PharmaPatents, (March 15, 2018)
  • Author, “Who’s Afraid of the Big Bad NCAA ?. . . The Ed O’Bannon v. NCAA Decision’s Impact on the NCAA Amateurism Model,” J. Corp. Law, Vol. 41.3 (2016)
  • Co-author, “Development of Quantitative Structure Activity Relationships for the Binding Affinity of Methoxypyridinium Cations for Human Acetylcholinesterase,” J. Mol. Graphics and Modelling (2015)
  • Co-author, “Reversible Inhibition of Human Acetylcholinesterase by Methoxypyridinium Species,” Bioorg. Med. Chem. Lett. (2013)
  • Co-author, “Experimental Determination of the Dissolution Kinetics of Zero-Valent Iron in the Presence of Organic Complexants,” Env. Chem. (2007)